Aura Biosciences Ownership | Who Owns Aura Biosciences?
Aura Biosciences Ownership Summary
Aura Biosciences is owned by 79.51% institutional investors, 1.65% insiders, and 18.84% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 13.94% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.
AURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aura Biosciences | 79.51% | 1.65% | 18.84% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Matrix capital management company, lp | 6.92M | 13.94% | $56.91M |
| Adage capital partners gp | 4.88M | 9.83% | $40.12M |
| Blackrock funding, inc. /de | 3.55M | 7.15% | $29.19M |
| Medicxi ventures management (jersey) | 3.04M | 6.12% | $24.99M |
| Blackrock | 3.01M | 6.08% | $22.72M |
| Long focus capital management | 2.54M | 5.11% | $20.86M |
| Vanguard group | 1.92M | 3.86% | $15.76M |
| Franklin resources | 1.72M | 3.47% | $14.16M |
| Nantahala capital management | 1.27M | 2.56% | $10.44M |
| Levin capital strategies | 1.25M | 2.51% | $10.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 3.04M | 4.72% | $24.99M |
| Regency capital management inc.\de | 609.42K | 2.71% | $5.01M |
| Matrix capital management company, lp | 6.92M | 2.65% | $56.91M |
| Levin capital strategies | 1.25M | 0.97% | $10.26M |
| Decheng capital | 515.55K | 0.91% | $4.24M |
| Long focus capital management | 2.54M | 0.68% | $20.86M |
| Nantahala capital management | 1.27M | 0.45% | $10.44M |
| Tbh global asset management | 60.32K | 0.12% | $495.85K |
| Ubs oconnor | 136.52K | 0.09% | $1.12M |
| Platinum investment management | 162.36K | 0.08% | $1.33M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Long focus capital management | 2.54M | 0.68% | 1.40M |
| Levin capital strategies | 1.25M | 0.97% | 833.98K |
| Ubs group | 687.32K | 0.00% | 665.34K |
| Blackrock | 3.01M | 0.00% | 560.52K |
| Blackrock funding, inc. /de | 3.55M | 0.00% | 391.04K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Eventide asset management | - | - | -4.08M |
| Ensign peak advisors | - | - | -390.69K |
| Jefferies financial group | - | - | -222.50K |
| Verition fund management | - | - | -151.68K |
| Adar1 capital management | - | - | -73.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna group, llp | 27.34K | - | 27.34K | $224.74K |
| Creative planning | 21.41K | 0.00% | 21.41K | $176.03K |
| Intech investment management | 20.93K | 0.00% | 20.93K | $172.01K |
| Gsa capital partners llp | 18.28K | 0.01% | 18.28K | $150.00K |
| Proshare advisors | 15.43K | 0.00% | 15.43K | $126.81K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Capital performance advisors llp | -25.00 |
| Us bancorp \de\ | -27.00 |
| Srs capital advisors | -102.00 |
| Group one trading | -189.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 94 | -3.09% | 39,855,409 | 1.03% | 79 | 1.26% | 43 | -27.12% | 30 | 76.47% |
| Dec 31, 2024 | 96 | 11.63% | 39,448,552 | 7.00% | 79 | 1.44% | 57 | 35.71% | 17 | -29.17% |
| Sep 30, 2024 | 86 | 13.16% | 36,866,668 | -6.95% | 74 | 1.16% | 41 | -8.89% | 25 | 25.00% |
| Jun 30, 2024 | 76 | -3.80% | 39,620,998 | 1.29% | 80 | 0.82% | 45 | -2.17% | 20 | 11.11% |
| Mar 31, 2024 | 79 | 8.22% | 39,115,323 | 5.72% | 98 | 1.05% | 46 | -9.80% | 18 | 63.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.08M | 8.16% | -1.72M |
| Franklin Biotechnology Discv A(acc)USD | 1.41M | 2.79% | 3.70K |
| Vanguard Total Stock Mkt Idx Inv | 1.02M | 2.03% | - |
| iShares Russell 2000 ETF | 1.18M | 1.90% | 576.00 |
| Franklin Biotechnology Discovery A | 780.22K | 1.55% | 1.58K |
| Vanguard Institutional Extnd Mkt Idx Tr | 609.87K | 1.21% | 2.96K |
| Fidelity Small Cap Index | 461.53K | 0.92% | - |
| T. Rowe Price Health Sciences | 349.61K | 0.70% | -5.28K |
| iShares Russell 2000 Value ETF | 426.43K | 0.69% | - |
| Vanguard Russell 2000 ETF | 229.84K | 0.46% | 12.83K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Johnson David Michael | - | Buy | $24.50K |
| May 16, 2025 | Johnson David Michael | - | Buy | $98.00K |
| May 16, 2025 | Gibney Anthony S | See Remarks | Sell | $7.82K |
| May 16, 2025 | Gibney Anthony S | See Remarks | Buy | $61.25K |
| May 16, 2025 | Gibney Anthony S | See Remarks | Buy | $245.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 4 | 3 |
| 2025 Q1 | - | 6 |
| 2024 Q4 | - | 6 |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
AURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools